(R)-2,5-Ddioxopyrrolidin-1-yl 2-((tert-butoxycarbonyl)amino)-3-phenylpropanoate, 98%, 25g

(S)-N1-(4-((3-CHLORO-4-FLUOROPHENYL)AMINO)-7-((TETRAHYDROFURAN-3-YL)OXY)QUINAZOLIN-6-YL)-N2,N2-DIMETHYLOXALAMIDE, 95%, 50mg

6-hydroxy-1,3-dimethyl-4-sulfanylidene-1,2,3,4-tetrahydropyrimidin-2-one, 97%, 1g

N-(2-((5-Chloro-2-((2-methoxy-4-morpholinophenyl)amino)pyrimidin-4-yl)amino)phenyl)methanesulfonamide, 98%, 100mg

2-Heptylcyclopentanone, 95.0%, 1g

Taurine, 99.0%, 250g

2,6-Dichloro-3-hydroxyisonicotinaldehyde, 95.0%, 250mg

trans-1-Bromo-2-butene, 85% (remainder 3-Bromo-1-butene), 85.0%, 5g

4-(4-methoxy-3-methylphenyl)-1,3-thiazol-2-amine, 95.0%, 1g

Oxazolo[5,4-b]pyridin-2-amine, 95.0%, 1g

4-Formyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid, 98%, 5g

6-Chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide, >95%, 1g

Isobutyric acid, >=99%, for synthesis, 250 ml, glass packaging